Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib

Hepatic epithelioid hemangioendothelioma (HEH) is a rare disease of unknown etiology for which a standard systemic treatment has not been established. The common expression of vascular endothelial growth factor (VEGF) and its receptor in HEH provide a rationale for the reported use of antiangiogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangro, Bruno, Iñarrairaegui, Mercedes, Fernández-Ros, Nerea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401162/
https://www.ncbi.nlm.nih.gov/pubmed/22826791
http://dx.doi.org/10.4081/rt.2012.e34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401162/
https://www.ncbi.nlm.nih.gov/pubmed/22826791
http://dx.doi.org/10.4081/rt.2012.e34

Ejemplares similares